Establishing secure connection…Loading editor…Preparing document…

Tissue Bank License Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Tissue Bank License Agreement

This Tissue Bank License Agreement (the Agreement) is made as of by and between Licensor: with principal place of business at , and Licensee: with principal place of business at .

Recitals

WHEREAS, Licensor is a tissue bank engaged in the collection, processing, storage and distribution of human tissue, tissue derivatives and associated data necessary for research and clinical applications (the Licensed Materials); and

WHEREAS, Licensee desires to obtain from Licensor a limited, non-transferable license to obtain, receive and use certain Licensed Materials solely for the Permitted Uses defined herein; and

WHEREAS, the parties intend to comply with all applicable laws, regulations and ethical standards governing the procurement, use and disposition of human tissue, including informed consent, privacy protections and biosafety; and

NOW THEREFORE, in consideration of the mutual covenants and agreements set forth below, the parties agree as follows:

1. Definitions

1.1 "Licensed Materials" means the specific tissue specimens, derivatives, and associated de-identified or identified data listed in Exhibit A and described in the Licensed Materials Description:

1.2 "Permitted Uses" means the limited uses for which Licensee is authorized to use the Licensed Materials as set forth in Section 3 below.

2. Grant of License

2.1 License. Subject to the terms and conditions of this Agreement, Licensor hereby grants to Licensee a non-exclusive, non-transferable, non-sublicensable license to receive, possess and use the Licensed Materials solely for the Permitted Uses during the Term.

2.2 Limitations. Licensee shall not sell, transfer, distribute, or otherwise provide Licensed Materials to any third party except as expressly authorized in writing by Licensor. Licensee shall not use Licensed Materials for human implantation or clinical transplantation unless expressly authorized in a written amendment to this Agreement.

3. Permitted Uses and Restrictions

3.1 Permitted Uses. Licensee may use the Licensed Materials solely for the following activities: research, method development, validation, quality control, and internal testing as specified here:

3.2 Privacy and Consent. Licensee shall comply with all applicable laws and regulations regarding informed consent, privacy and the protection of personal data. Licensee shall not attempt to re-identify de-identified donor information.

4. Regulatory Compliance; Permits

4.1 Compliance. Each party shall maintain all permits, licenses, registrations and approvals required by law for its respective activities under this Agreement. Licensee shall maintain Institutional Review Board or equivalent approvals as required for its use of Licensed Materials.

4.2 Notification. Licensee shall promptly notify Licensor in writing if Licensee becomes aware of any non-compliance or regulatory inquiry related to Licensed Materials.

5. Fees and Payment

5.1 Fees. In consideration for the license and supply of Licensed Materials, Licensee shall pay Licensor the fees set forth below and any additional charges reasonably incurred for handling, processing and shipping.

5.2 Payment Terms. Payments are due within days of invoice. Late payments shall accrue interest at the lesser of 1.5% per month or the maximum rate permitted by law.

6. Term and Termination

6.1 Term. This Agreement shall commence on the Effective Date and shall continue for an initial term of years, unless earlier terminated as set forth herein.

6.2 Termination for Cause. Either party may terminate this Agreement upon written notice if the other party materially breaches any provision of this Agreement and fails to cure within days after receipt of notice.

6.3 Effect of Termination. Upon termination or expiration, Licensee shall cease all use of Licensed Materials and, at Licensor's election, return or destroy Licensed Materials and provide a certificate of destruction.

7. Recordkeeping and Audit

7.1 Records. Licensee shall maintain complete and accurate records relating to its receipt, storage, use and disposition of Licensed Materials for a period of years following the date of use or destruction.

7.2 Audit. Licensor or its designee shall have the right, upon reasonable prior notice and during normal business hours, to audit Licensee's records and facilities to verify compliance. Any such audit shall be conducted in a manner designed to minimize interruption to Licensee's operations.

8. Warranties; Disclaimers

8.1 Licensor Warranties. Licensor represents and warrants that it has obtained, to the extent required by applicable law, all consents and authorizations necessary to provide the Licensed Materials for the Permitted Uses and that it will provide Licensed Materials in accordance with the specifications set forth in Exhibit A.

8.2 Disclaimer. EXCEPT AS EXPRESSLY SET FORTH IN SECTION 8.1, THE LICENSED MATERIALS ARE PROVIDED "AS IS" AND LICENSOR DISCLAIMS ALL OTHER WARRANTIES, WHETHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT.

9. Indemnification; Insurance

9.1 Indemnification by Licensee. Licensee shall indemnify, defend and hold harmless Licensor and its officers, directors and employees from and against any claims, liabilities, losses, damages, costs and expenses (including reasonable attorneys' fees) arising out of Licensee's negligent or willful misuse of Licensed Materials or breach of this Agreement.

9.2 Insurance. Licensee shall maintain insurance coverage sufficient to cover its obligations under this Agreement, including general liability and professional liability as applicable, and shall provide certificates of insurance upon request.

10. Confidentiality

10.1 Confidential Information. Each party shall maintain in confidence all non-public information disclosed by the other party that is designated as confidential or that reasonably should be understood to be confidential, including donor information and proprietary processing methods.

10.2 Exceptions. Confidential information does not include information that is or becomes publicly available through no fault of the receiving party or that is rightfully received from a third party without restriction.

11. Intellectual Property

11.1 Ownership. Licensor retains all right, title and interest in and to the Licensed Materials and any proprietary methods, procedures or clinical data owned by Licensor prior to or independent of this Agreement. Licensee shall not acquire any ownership interest in such Licensor property by virtue of this Agreement.

12. Biohazard and Safety

12.1 Safety Standards. Licensee shall handle, store and dispose of Licensed Materials in accordance with applicable biosafety laws and standards, including using appropriate containment, training personnel and maintaining biosafety protocols.

13. Notices

All notices required under this Agreement shall be in writing and delivered to the parties at their addresses set forth above or to such other address as a party may designate by written notice to the other party. Notice contact person for Licensor:

14. Amendments; Waiver; Counterparts

14.1 Amendments. This Agreement may be amended only by a written instrument executed by both parties.

14.2 Waiver. No failure or delay by either party in exercising any right shall operate as a waiver of that right.

14.3 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument.

15. Governing Law; Venue

This Agreement shall be governed by and construed in accordance with the laws of the state identified below without regard to conflict of laws principles. The parties submit to the exclusive jurisdiction of the courts located in that state for disputes arising under this Agreement.

16. Entire Agreement; Severability

16.1 Entire Agreement. This Agreement, including any exhibits attached hereto, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings.

16.2 Severability. If any provision of this Agreement is held to be invalid or unenforceable, the remaining provisions shall remain in full force and effect.

17. Miscellaneous

17.1 Assignment. Neither party may assign or delegate its rights or obligations under this Agreement without the prior written consent of the other party, except that Licensor may assign to an affiliate or successor in interest.

17.2 Relationship of Parties. The parties are independent contractors. Nothing in this Agreement shall be construed to create a partnership, joint venture or agency relationship.

18. Exhibits

The following exhibits are attached and incorporated by reference: Exhibit A — Licensed Materials Specification; Exhibit B — Fees and Billing Schedule.

Licensor:

By:

Date:

Licensee:

By:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What the Tissue Bank License Agreement Covers

A Tissue Bank License Agreement is a contractual document that governs the donation, transfer, storage, and permitted uses of human tissue between a tissue bank and a receiving party such as a research institution, clinical laboratory, or commercial partner. It sets terms for consent verification, scope of permitted research or clinical use, ownership or custodial responsibility, data and specimen handling, confidentiality, indemnity, and compliance with applicable law. The agreement also allocates risk, specifies retention of records, and clarifies obligations for destruction or return of material at termination or upon request.

Why a Clear License Agreement Matters

A well-drafted Tissue Bank License Agreement reduces legal risk, documents informed consent and permitted uses, preserves donor privacy, and supports regulatory compliance with HIPAA and research rules. It clarifies liability, intellectual property expectations, and requirements for data sharing or de-identification.

Why a Clear License Agreement Matters

Who Typically Prepares and Signs This Agreement

The agreement is used by tissue banks, hospitals, research labs, and companies that need human tissue for clinical or research purposes.

  • Tissue banks and biorepositories responsible for specimen custody and compliance with donor consents.
  • Academic and commercial research organizations that receive tissue for studies or assays.
  • Clinical laboratories or diagnostic vendors that use tissue for test development or validation.

Multiple parties often review the draft: legal counsel, compliance officers, research directors, and laboratory managers before execution.

Who Signs and Their Roles

Bank Signatory, Director

The tissue bank signatory is typically an authorized institutional officer or director who attests to chain-of-custody, donor consent status, and that the bank holds rights to distribute the material. This signer must ensure the agreement aligns with internal policies and applicable human-subjects requirements.

Recipient Signatory, Institutional Officer

The recipient signatory is usually a senior institutional official (research director, contracting officer, or general counsel) who accepts terms for permitted use, reporting obligations, disposal or return procedures, and indemnification responsibilities on behalf of the receiving organization.

Core Provisions to Include in a Professional Agreement

A complete Tissue Bank License Agreement should explicitly address consent, permitted uses, data access, IP, liability, and termination procedures.

Consent & Donor Limits

Describe donor consent scope, restrictions on use (clinical vs research), and whether identifiable data accompanies the tissue; include any IRB or ethics approvals required.

Permitted Uses

List allowed activities (research, diagnostic development, commercialization) and prohibit unauthorized procedures such as human implantation if not consented.

Confidentiality

Define confidential information, permitted disclosures, data de-identification standards, and obligations under HIPAA where PHI is present.

Intellectual Property

State ownership or license terms for derivatives, discoveries, and improvements that arise from using the tissue, plus any revenue-sharing arrangements.

Liability & Indemnity

Allocate risk for misuse, contamination, or regulatory violations; include insurance requirements and mutual indemnities where appropriate.

Return/Destruction

Specify conditions and timelines for returning or securely destroying remaining specimens and related data at termination or upon donor revocation.

Step-by-Step: Completing the Agreement

Follow a consistent review and authorization path to ensure compliance and timely execution.

  • 01
    Draft: Populate parties, scope, and specimen details.
  • 02
    Legal Review: Have institutional counsel review consent and IP language.
  • 03
    Compliance Check: Confirm HIPAA, IRB, and biosafety approvals.
  • 04
    Execution: Obtain authorized signatures and retain executed copy.

How to Configure an Online Completion Workflow

Set roles, authentication, and routing to align with institutional approval requirements and recordkeeping.

Field Configuration
Signer Sequence Order signatures: bank first, recipient second.
Authentication Use email plus SMS or 2FA for higher assurance.
Attachment Rules Require consent forms and IRB approval uploads.
Audit Trail Enable full timestamps, IP, and transaction logs.

Where to File, Send, and Store Executed Agreements

Use established custody and records systems and confirm routing for compliance and access control.

  • Repository: Store executed agreement in secure records system.
  • Compliance Office: Send copy to institutional compliance or privacy office.
  • Research Team: Provide redacted copy to principal investigator.
  • Donor Records: Link agreement to donor consent files.

Digital Signing and eSubmission Considerations

Choose an eSignature workflow that supports required authentication, audit trails, and secure storage for sensitive health-related materials.

  • Authentication: Email, SMS, or KBA options.
  • Audit Trail: Time-stamped, tamper-evident record.
  • File Formats: PDF/A or DOCX supported.

Ensure the chosen platform supports HIPAA (BAA available), produces detailed audit logs, and integrates with institutional storage (e.g., Box, Google Drive, NetSuite) to maintain chain-of-custody and retention records.

Typical eSignature Vendor Comparison for Licensing Workflows

Comparison focuses on starter pricing, trial availability, bulk-send capability, audit trail presence, HIPAA support, and envelope limits to help evaluate providers for Tissue Bank License Agreement workflows.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial No No Yes, limited Yes, limited
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Data and Security Essentials to Note

Encryption: TLS 1.2/1.3; AES-256 at rest
Audit Trail: Timestamps and IP logs
HIPAA: BAA required if PHI present
Access Controls: Role-based permissions
File Formats: PDF/A recommended
Certifications: SOC 2 Type II, ISO 27001

Key Risks and Potential Consequences

HIPAA Violation: Civil/criminal penalties
Consent Mismatch: Regulatory enforcement risk
IP Dispute: Litigation and injunction
Data Breach: Notification and fines
Contract Breach: Damages and termination
Retention Failure: Compliance penalties

Common Preparation Pitfalls to Avoid

  • Failing to match the donor consent to permitted uses can expose parties to regulatory risk and force cessation of research activities.
  • Vague specimen descriptions or quantities create operational disputes about what was delivered and what remains for future use.
  • Omitting IP or commercialization clauses can lead to downstream ownership disputes if discoveries or products result.
  • Not aligning data access rules with HIPAA or institutional policies increases the chance of unauthorized disclosure and fines.

Practical Tips for Accurate and Efficient Completion

Adopt consistent templates, review checklists, and electronic workflows to reduce errors and accelerate execution.

Use a Standard Template
Maintain an institution-approved template that embeds required consent cross-references, IRB clauses, and signature blocks to ensure consistency and speed up legal review.
Confirm Consent Scope
Verify donor consent documentation and any donor-specified restrictions before completing the agreement to avoid later compliance or ethical conflicts.
Leverage Secure eSignature
Choose an eSignature provider that supports audit trails, HIPAA compliance when needed, and integrations with secure repositories to preserve chain-of-custody.
Retain Executed Records
Store signed agreements and supporting documents in a secure, access-controlled system and map retention schedules to applicable federal and state rules.

Frequently Asked Questions and Practical Answers

Answers address common execution, compliance, and records questions encountered when preparing Tissue Bank License Agreements.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.